| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Revenue | $417.1M | -17.7% |
| Cost of Revenue | $316.4M | -33.6% |
| Gross Profit | $100.7M | +234.3% |
| R&D Expense | $141.3M | -36.0% |
| SG&A Expense | $81.5M | -25.3% |
| Operating Income | -$253.0M | +43.8% |
| Interest Expense | $24.7M | +51.5% |
| Pre-tax Income | -$272.7M | +40.4% |
| Income Tax | $4.4M |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $224.6M | -31.4% |
| Accounts Receivable | $95.9M | -22.7% |
| Inventory | $209.3M | +5.4% |
| Current Assets | $566.6M | -23.7% |
| Total Assets | $898.2M | -18.6% |
| Current Liabilities | $293.7M | -11.0% |
| Long-term Debt | $297.1M | +4.7% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$146.9M | +55.3% |
| Capital Expenditures | $12.1M | -37.8% |
| Investing Cash Flow | -$12.1M | -114.1% |
| Financing Cash Flow | $28.5M | -90.7% |
| Free Cash Flow | -$159.0M | +54.4% |
| — |
| Net Income | -$277.1M | +39.5% |
| EPS (Basic) | -$0.64 | +47.5% |
| EPS (Diluted) | -$0.64 | +47.5% |
| Total Liabilities |
| $760.7M |
| -1.9% |
| Stockholders' Equity | $137.5M | -58.0% |